Evidence map›Paper›PMID 37347793›Full record

ArticleDiabetes2023

Identification of Hypothalamic Glucoregulatory Neurons That Sense and Respond to Changes in Glycemia.

Jennifer D Deem, David Tingley, Anne-Mette Bjerregaard, Anna Secher, Owen Chan, Chukwuemeka Uzo, Nicole E Richardson, Elizabeth Giering, Tammy Doan, Bao A Phan and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Brain Nutrient Sensing: A Unifying Framework.Annual review of physiology · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Jennifer D DeemUniversity of Washington Medicine Diabetes Institute, Department of Medicine, University of Washington, Seattle, WA.
David TingleyBeth Israel-Deaconess Medical Center, Harvard University School of Medicine, Boston, MA.
Anne-Mette BjerregaardData Science Intelligence, Global Drug Discovery, Novo Nordisk A/S, Maaloev, Denmark.
Anna SecherData Science Intelligence, Global Drug Discovery, Novo Nordisk A/S, Maaloev, Denmark.
Owen ChanDepartment of Internal Medicine, University of Utah, Salt Lake City, UT.ORCID 0000-0002-6652-1066
Chukwuemeka UzoDepartment of Internal Medicine, University of Utah, Salt Lake City, UT.
Nicole E RichardsonUniversity of Washington Medicine Diabetes Institute, Department of Medicine, University of Washington, Seattle, WA.
Elizabeth GieringUniversity of Washington Medicine Diabetes Institute, Department of Medicine, University of Washington, Seattle, WA.
Tammy DoanUniversity of Washington Medicine Diabetes Institute, Department of Medicine, University of Washington, Seattle, WA.
Bao A PhanUniversity of Washington Medicine Diabetes Institute, Department of Medicine, University of Washington, Seattle, WA.
Brandon WuUniversity of Washington Medicine Diabetes Institute, Department of Medicine, University of Washington, Seattle, WA.
Jarrad M ScarlettUniversity of Washington Medicine Diabetes Institute, Department of Medicine, University of Washington, Seattle, WA.ORCID 0000-0003-1019-346X
Gregory J MortonUniversity of Washington Medicine Diabetes Institute, Department of Medicine, University of Washington, Seattle, WA.ORCID 0000-0002-8106-8386
Michael W SchwartzUniversity of Washington Medicine Diabetes Institute, Department of Medicine, University of Washington, Seattle, WA.ORCID 0000-0003-1619-0331
University of Washington · USNovo Nordisk (Denmark) · DKUniversity of Utah · USBeth Israel Deaconess Medical Center · USSeattle Children's Hospital · US

Funding

Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Sakeneh Zraika · 1986 to 2026
$41.4M
PILOT STUDY--CLINICAL NUTRITION RESEARCHP30DK035816 · NIDDK · UNIVERSITY OF WASHINGTON · PI GREGORY J MORTON · 1986 to 2026
$30.4M
Diabetes, Obesity and Metabolism Training ProgramT32DK007247 · NIDDK · UNIVERSITY OF WASHINGTON · PI GREGORY J MORTON, KRISTINA Marie UTZSCHNEIDER · 1986 to 2026
$10.0M
Novel Brain Mechanisms Controlling Glucose HomeostasisR01DK083042 · NIDDK · UNIVERSITY OF WASHINGTON · PI SCHWARTZ, MICHAEL W · 2008 to 2025
$7.6M
Therapeutic Potential of Kappa Antagonists in the Adjunctive Treatment of Psychotic DepressionP50MH106428 · NIMH · UNIVERSITY OF WASHINGTON · PI CHAVKIN, CHARLES · 2015 to 2019
$7.6M
Nutrition, Obesity and Atherosclerosis Training ProgramT32HL007028 · NHLBI · UNIVERSITY OF WASHINGTON · PI Karin E Bornfeldt · 1985 to 2026
$6.4M
Neuroendocrine Control of Glucose MetabolismR01DK089056 · NIDDK · UNIVERSITY OF WASHINGTON · PI MORTON, GREGORY J · 2011 to 2024
$5.6M
Thermoregulatory circuits that regulate feedingR01DK124238 · NIDDK · UNIVERSITY OF WASHINGTON · PI GREGORY J MORTON, Tune Hannes Pers · 2020 to 2026
$3.9M
Novel Anti-Diabetic Actions of Hypothalamic FGF19-FGFR1 SignalingR01DK101997 · NIDDK · UNIVERSITY OF WASHINGTON · PI SCHWARTZ, MICHAEL W · 2014 to 2018
$1.9M
Regulation of energy and glucose homeostasis by endogenous hypothalamic FGF1R03DK128383 · NIDDK · UNIVERSITY OF WASHINGTON · PI SCARLETT, JARRAD M · 2021 to 2022
$265k
NHLBI NIH HHS T32 HL007028NIDDK NIH HHS P30 DK017047NIDDK NIH HHS P30 DK035816NIDDK NIH HHS R01 DK083042NIDDK NIH HHS R01 DK089056NIDDK NIH HHS R01 DK101997NIDDK NIH HHS R01 DK124238NIDDK NIH HHS R03 DK128383NIDDK NIH HHS T32 DK007247NIH HHS DK007247NIMH NIH HHS P50 MH106428
6 · The paper itself

Abstract

To investigate whether glucoregulatory neurons in the hypothalamus can sense and respond to physiological variation in the blood glucose (BG) level, we combined continuous arterial glucose monitoring with continuous measures of the activity of a specific subset of neurons located in the hypothalamic ventromedial nucleus that express pituitary adenylate cyclase activating peptide (VMNPACAP neurons) obtained using fiber photometry. Data were collected in conscious, free-living mice during a 1-h baseline monitoring period and a subsequent 2-h intervention period during which the BG level was raised either by consuming a chow or a high-sucrose meal or by intraperitoneal glucose injection. Cross-correlation analysis revealed that, following a 60- to 90-s delay, interventions that raise the BG level reliably associate with reduced VMNPACAP neuron activity (P < 0.01). In addition, a strong positive correlation between BG and spontaneous VMNPACAP neuron activity was observed under basal conditions but with a much longer (∼25 min) temporal offset, consistent with published evidence that VMNPACAP neuron activation raises the BG level. Together, these findings are suggestive of a closed-loop system whereby VMNPACAP neuron activation increases the BG level; detection of a rising BG level, in turn, feeds back to inhibit these neurons. To our knowledge, these findings constitute the first evidence of a role in glucose homeostasis for glucoregulatory neurocircuits that, like pancreatic β-cells, sense and respond to physiological variation in glycemia. ARTICLE HIGHLIGHTS: By combining continuous arterial glucose monitoring with fiber photometry, studies investigated whether neurons in the murine ventromedial nucleus that express pituitary adenylate cyclase activating peptide (VMNPACAP neurons) detect and respond to changes in glycemia in vivo. VMNPACAP neuron activity rapidly decreases (within <2 min) when the blood glucose level is raised by either food consumption or glucose administration. Spontaneous VMNPACAP neuron activity also correlates positively with glycemia, but with a longer temporal offset, consistent with reports that hyperglycemia is induced by experimental activation of these neurons. Like pancreatic β-cells, neurons in the hypothalamic ventromedial nucleus appear to sense and respond to physiological variation in glycemia.

Indexed as

Blood GlucoseBlood Glucose Self-MonitoringAdenylyl CyclasesAnimalsGlucoseHypothalamusMiceNeuronsPeptidesAdenylyl CyclasesBlood GlucoseGlucosePeptides

Identifiers

PMID37347793
PMCPMC10450823
OpenAlexW4381611260

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.